Allianz Asset Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-17,000
Closed -$667K 2306
2025
Q1
$667K Buy
17,000
+1,000
+6% +$45K ﹤0.01% 1787
2024
Q4
$744K Hold
16,000
﹤0.01% 1734
2024
Q3
$723K Hold
16,000
﹤0.01% 1743
2024
Q2
$788K Buy
+16,000
New +$652K ﹤0.01% 1670
2022
Q3
Sell
-1,560,172
Closed -$54.5M 2129
2022
Q2
$54.5M Sell
1,560,172
-48,465
-3% -$1.72M 0.05% 374
2022
Q1
$79.4M Sell
1,608,637
-11,301
-0.7% -$626K 0.06% 336
2021
Q4
$125M Sell
1,619,938
-108,200
-6% -$11.1M 0.09% 256
2021
Q3
$185M Buy
1,728,138
+76,905
+5% +$8.81M 0.14% 151
2021
Q2
$220M Sell
1,651,233
-52,377
-3% -$6.09M 0.19% 114
2021
Q1
$211M Buy
1,703,610
+1,592,545
+1,434% +$242M 0.2% 110
2020
Q4
$15.7M Buy
111,065
+16,446
+17% +$1.82M 0.02% 695
2020
Q3
$7.19M Sell
94,619
-53,148
-36% -$3.31M 0.01% 866
2020
Q2
$6.69M Buy
147,767
+63,018
+74% +$2.26M 0.01% 1068
2020
Q1
$2.59M Buy
84,749
+18,202
+27% +$489K ﹤0.01% 1431
2019
Q4
$1.4M Buy
66,547
+16,751
+34% +$392K ﹤0.01% 2047
2019
Q3
$1.19M Buy
+49,796
New +$1.45M ﹤0.01% 2052

Other funds holding TWST

Allianz Asset Management's TWST Position: Q2 2025 in Review

Allianz Asset Management sold out of Twist Bioscience (TWST) in Q2 2025, closing a stake of 17,000 shares — an estimated $667K sold.

Allianz Asset Management first reported a position in TWST in Q3 2019 and held it in 16 quarters. The position peaked at $220M in Q2 2021. 244 funds tracked by Wall St. Rank hold TWST as of Q2 2025.

  • Allianz Asset Management reported no remaining Twist Bioscience position as of Q2 2025 after selling out during the quarter.
  • Allianz Asset Management sold 17,000 Twist Bioscience shares in Q2 2025, an estimated $667K.
  • Allianz Asset Management first reported a position in Twist Bioscience in Q3 2019 and held it in 16 quarters.
  • Allianz Asset Management's Twist Bioscience position peaked at $220M in Q2 2021.
  • 244 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2025.

Based on Allianz Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.